期刊文献+

消化系统恶性肿瘤患者细胞免疫与体液免疫功能分析及意义 被引量:2

下载PDF
导出
摘要 目的:探讨消化系统恶性肿瘤患者细胞免疫与体液免疫功能及意义。方法:选取2012年2月至2018年7月间因消化系统恶性肿瘤疾病于山东中医药大学附属医院收治的129例患者作为研究对象中的观察组,同期体检的86例健康人员作为对照组。对比两组的T淋巴细胞亚群与血清免疫球蛋白IgG、IgA、IgM水平,并分析恶性肿瘤患者细胞免疫与体液免疫功能及意义。结果:观察组CD3^+、CD4^+及CD4^+/CD8^+水平均显著低于对照组,CD8+显著高于对照组(P<0.05),IgG、IgA、IgM水平均显著高于对照组(P<0.05)。结论:通过对T淋巴细胞亚群和血清免疫球蛋白的检测,有助于临床监测消化道恶性肿瘤患者的细胞免疫及体液免疫状态,对掌握患者机体免疫情况、疾病发展,制定后续的治疗具有重要意义。
作者 秦榛 许晓群
出处 《现代消化及介入诊疗》 2018年第A01期49-50,共2页 Modern Interventional Diagnosis and Treatment in Gastroenterology
  • 相关文献

参考文献4

二级参考文献54

  • 1范圣登,徐骅,丁洁,卜晓萱,李琼,邱国强,沈志忠.输血对肠癌患者围术期细胞免疫功能的影响[J].江苏医药,2005,31(8):573-575. 被引量:9
  • 2Kelly JM,Darcy PK,Markby JL,et al.Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection[J].Nat Immunol,2002,3(1):83-90.
  • 3Goto S,Sato M,Kaneko R,et al.Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients[J].Cancer Immunol Immunother,1999,48(8):435-442.
  • 4Kjaergaard J,Hokland ME,Agger R,et al.Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals[J].Cancer Immunol Immunother,2000,48(10):550-560.
  • 5Metelitsa LS,Naidenko OV,Kant A,et al. Human NK T cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells[J].J Immunol,2001,167(6):3114-3122.
  • 6Codfrey DI,Hammond KJ,Poulton LD,et al.NKT cells: facts,functions and fallacies[J].Immunol Today,2000,21(11):573-583.
  • 7Tsukishiro T,Donnenberg AD,Whiteside TL.Rapid turnover of the CD8^+ CD28^+ T-cell subset of effector cells in the circulation of patients with head and neck cancer[J].Cancer Immunol Immunother,2003,52(10):599-607.
  • 8Kay NE,Leong TL,Bone N,et al.Blood levels of immune cells predict survival in myeloma patients:results of an Eastern Cooperative Oncology Group Phase 3 trial for newly diagnosed multiple myeloma patients[J].Blood,2001,98(1):23-28.
  • 9Melichar B,Touskova M,Solichova D,et al.CD4^+ T T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours[J].Scand J Clin Lab Investig,2001,61(5):363-370.
  • 10Kuss I,Donnenberg A,Gooding W,et al.Effector CD8^+ CD4^+T5RO CD27^+T cells have signaling defects in patients with head and neck cancer[J].Br J Cancer,2003,88(2):223-230.

共引文献26

同被引文献33

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部